TIAA CREF INVESTMENT MANAGEMENT LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$7,069,000
-50.6%
384,160
-29.8%
0.01%
-54.5%
Q4 2018$14,308,000
-57.1%
547,557
-62.3%
0.01%0.0%
Q3 2018$33,370,000
+155.6%
1,454,046
+112.2%
0.01%
+22.2%
Q2 2018$13,056,000
+50.1%
685,336
+32.8%
0.01%
+50.0%
Q1 2018$8,696,000
+28.1%
516,082
+15.6%
0.01%
+50.0%
Q4 2017$6,787,000
-10.8%
446,482
+5.1%
0.00%
-20.0%
Q3 2017$7,605,000
+50.7%
424,887
+37.2%
0.01%
+25.0%
Q2 2017$5,048,000
-11.8%
309,682
-24.3%
0.00%0.0%
Q1 2017$5,725,000
-7.8%
408,952
+5.1%
0.00%
-20.0%
Q4 2016$6,209,000
-1.5%
389,278
+2.7%
0.01%
+25.0%
Q3 2016$6,306,000
+88.6%
378,964
+26.8%
0.00%
+33.3%
Q2 2016$3,343,000
+89.3%
298,773
+41.4%
0.00%
+200.0%
Q1 2016$1,766,000
+40.9%
211,246
+57.0%
0.00%0.0%
Q4 2015$1,253,000
-17.5%
134,5460.0%0.00%0.0%
Q3 2015$1,518,000
-7.3%
134,546
+4.2%
0.00%0.0%
Q2 2015$1,638,000
+37.3%
129,115
+0.7%
0.00%0.0%
Q1 2015$1,193,000
-83.5%
128,249
-74.5%
0.00%
-80.0%
Q4 2014$7,213,000
+36.9%
503,695
-0.8%
0.01%
+25.0%
Q3 2014$5,268,000
-39.2%
507,502
-5.2%
0.00%
-33.3%
Q2 2014$8,661,000
+23.0%
535,303
+23.5%
0.01%
+20.0%
Q1 2014$7,041,000
+26.3%
433,278
-3.6%
0.01%
+25.0%
Q4 2013$5,577,000
+4.0%
449,394
-8.1%
0.00%0.0%
Q3 2013$5,362,000
+38.1%
488,790
+1.7%
0.00%
+33.3%
Q2 2013$3,882,000480,4290.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders